We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Scolds Merck About Conditions At Pa. Plant

Law360 (May 1, 2008, 12:00 AM EDT) -- Following a nearly two-month inspection of a Merck & Co. Inc. plant in Pennsylvania, the U.S. Food and Drug Administration sent the company a warning letter this week outlining what it calls “significant objectionable conditions” at the plant.

The violations are described by the FDA as “inadequate investigations of deviations and failure to maintain production and process controls,” including instances in which unnecessary fibers ended up in vaccine vials.

Nevertheless, the FDA says on its Web site that it “does not believe that the issues identified...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.